Replies to post #1872 on XTL Biopharmaceuticals Ltd. (XTLB)

[stock1ace1]

Company is seeking merger / partnership The Company is expanding its IP portfolio surrounding hCDR1 and has decided, at this time, to explore cooperation with a strategic partner in order to execute its clinical trials. In parallel, the Company will look to expand and identify additional assets to add to XTL’s portfolio.

[stock1ace1]

$3.62 Macd crossover #bullish -> https://stockcharts.com/h-sc/ui?s=Xtlb